I'm glad you are interested as well.
Please note the word Speaker at the top.
In the 12.30 to 2pm period there are 34 entries with Mx Margeaux Hodgson-Garns featuring twice.
In 90 minutes that less than 3 minutes each - (if everyone speaks and time is allocated evenly) barely time to read much more than the abstracts, arguably.
In my opinion Mx Margeaux other abstract is also relevant to iPSC derived MSCs. Remember seeing a paper in which hanging drop MSCs had a different secretome to those from 2D plastic manufacture?
This should have been video'd and shared - there is potential for a somewhat false market here in that information is made available to some (obviously Mx Margeau hxxself - though that could be adequately protected with non disclosure agreements and similar protections and other protections against releasing information that could be traded upon) and not others (those actually at the poster presentations).
Some of the basic research being done - precisely because it is basic research - has the potential to discover problems with the assumptions behind CYPs value proposition thesis that its been talking up for years now as well as to "further support" it.
I'm for using universities and students to learn and keep costs down but I'm not for some having access to more market sensitive information than others - I don't think those attending poster presentations will be signing non disclosure agreements.
Any publicly discussed or revealed information should be recorded and shared via the CYP website. This announcement should have been made in time to give people the opportunity to decide to travel to attend.
- Forums
- ASX - By Stock
- Ann: Conference Data Demonstrating Consistency of Cynata MSCs
CYP
cynata therapeutics limited
Add to My Watchlist
9.68%
!
17.0¢

I'm glad you are interested as well. Please note the word...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
17.0¢ |
Change
0.015(9.68%) |
Mkt cap ! $38.41M |
Open | High | Low | Value | Volume |
15.5¢ | 17.0¢ | 15.5¢ | $47.10K | 289.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 23813 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 50000 | 0.165 |
4 | 47240 | 0.155 |
4 | 161673 | 0.150 |
1 | 5000 | 0.145 |
2 | 45000 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 18813 | 2 |
0.175 | 55250 | 1 |
0.180 | 62619 | 3 |
0.185 | 35990 | 1 |
0.195 | 19300 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online